Bacterial Protein Azurin as a Novel Anticancer Agent.

AuthID
P-00G-2E1
5
Author(s)
Yamada, T
·
Das Gupta, TK
Document Type
Abstract
Year published
2005
Published
in CLINICAL CANCER RESEARCH, ISSN: 1078-0432
Volume: 11, Issue: 24, Pages: 9039S-9040S (2)
Conference
Aacr/Nci/Eortc International Conference on Molecular Targets and Cancer Therapeutics, Date: NOV 14-18, 2005, Location: Philadelphia, PA, Sponsors: AACR, NCI, EORTC, AMGEN, AstraZeneca, Britol-Myers Squibb Co, Pfizer, Sanofi Aventis, Bayer Hlth Car Pharmaceut, Lilly, Genentech, GSK GlaxoSmithKline, Johnson &Johnson, MERCK, NOVARTIS ONCOL, Centocor, OSI Oncol, Schering-Plough, BTG, Servier, RADPHARM, Cvitkovic & Associes
Indexing
Publication Identifiers
Wos: WOS:000234382700304
Source Identifiers
ISSN: 1078-0432
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.